Research programme: serotonin 5HT1a agonist - CenomedAlternative Names: CBE; CM-2,385
Latest Information Update: 16 Jul 2016
At a glance
- Originator Cenomed BioSciences
- Mechanism of Action Serotonin 1A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Nausea and vomiting
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Nausea and vomiting in USA
- 21 Oct 2009 Preclinical trials in Nausea and vomiting in USA (unspecified route)